相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Safety and efficacy of everolimus-versus sirolimus-eluting stents: A systematic review and meta-analysis of 11 randomized trials
Kyung Woo Park et al.
AMERICAN HEART JOURNAL (2013)
Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials
Sripal Bangalore et al.
CIRCULATION (2012)
Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials
Antoinette de Waha et al.
CLINICAL RESEARCH IN CARDIOLOGY (2012)
Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction The COMFORTABLE AMI Randomized Trial
Lorenz Raeber et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Primary Endpoint Results of the EVOLVE Trial A Randomized Evaluation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
Ian T. Meredith et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
Tullio Palmerini et al.
LANCET (2012)
Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
Manel Sabate et al.
LANCET (2012)
Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings
Kumaran Kolandaivelu et al.
CIRCULATION (2011)
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial
Julinda Mehilli et al.
LANCET (2011)
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial
Giulio G. Stefanini et al.
LANCET (2011)
Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
William Wijns et al.
EUROPEAN HEART JOURNAL (2010)
Clinical and Angiographic Outcomes After Treatment of De Novo Coronary Stenoses With a Novel Platinum Chromium Thin-Strut Stent Primary Results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) Trial
Dean J. Kereiakes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
Elvin Kedhi et al.
LANCET (2010)
Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Drug-eluting versus bare metal stents in patients with ST-segment-elevation myocardial infarction -: Eight-month follow-up in the drug elution and distal protection in acute myocardial infarction (DEDICATION) trial
Henning Kelbaek et al.
CIRCULATION (2008)
Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients - An autopsy study
Gaku Nakazawa et al.
CIRCULATION (2008)
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
Stephan Windecker et al.
LANCET (2008)
Evaluation of networks of randomized trials
Georgia Salanti et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2008)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents - An observational study of drug-eluting versus bare-metal stents
Matthias Pfisterer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious?
R Virmani et al.
CIRCULATION (2004)
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
GW Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Combination of direct and indirect evidence in mixed treatment comparisons
G Lu et al.
STATISTICS IN MEDICINE (2004)
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
EP McFadden et al.
LANCET (2004)
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
M Morice et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
